Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

ITOCHU Technology Ventures

Investor type Venture Capital

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 141
Average round size
info
The average size of a deal this fund participated in
$10M
Portfolio companies 110
Rounds per year 6.41
Lead investments 16
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.22
Exits 42
Key employees 6
Stages of investment
Early Stage Venture
Late Stage Venture
Seed

Areas of investment

  • Information Technology
  • Software
  • E-Commerce
  • Internet
  • Mobile
Summary

ITOCHU Technology Ventures appeared to be the VC, which was created in 2000. The leading representative office of defined VC is situated in the Tokyo. The fund was located in Asia if to be more exact in Japan.

For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. The fund has no specific favorite in a number of founders of portfolio startups. When startup sums 5+ of the founder, the probability for it to get the investment is little. Among the most popular fund investment industries, there are Retail, SaaS. Among the various public portfolio startups of the fund, we may underline Mercari, Box, Rescale Besides, a startup needs to be aged 2-3 years to get the investment from the fund.

The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the ITOCHU Technology Ventures, startups are often financed by CyberAgent Capital, GREE Ventures, DFJ. The meaningful sponsors for the fund in investment in the same round are Mitsubishi UFJ Capital, YJ Capital, GREE Ventures. In the next rounds fund is usually obtained by Global Brain Corporation, Eight Roads Ventures, World Innovation Lab (WiL).

We also calculated 6 valuable employees in our database.

The increased amount of exits for fund were in 2015. The average startup value when the investment from ITOCHU Technology Ventures is 500 millions - 1 billion dollars. The common things for fund are deals in the range of 10 - 50 millions dollars. The high activity for fund was in 2013. Despite it in 2019 the fund had an activity. The fund is constantly included in 2-6 investment rounds annually. Comparing to the other companies, this ITOCHU Technology Ventures performs on 4 percentage points less the average number of lead investments. Speaking about the real fund results, this VC is 5 percentage points less often commits exit comparing to other organizations.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of ITOCHU Technology Ventures:
Typical Co-investors
ITOCHU Technology Ventures is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after ITOCHU Technology Ventures:

Funds with similar focus

Funds from Japan
Funds with similar focus located in Japan:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

OriCiro Genomics

Biotechnology
Innovation Management
Life Science
05 Jun 2022 Chiyoda, Japan

Beatrust

Communities
Information Services
Information Technology
$7M26 Apr 2022 Chiyoda, Japan

OriCiro Genomics

Biotechnology
Innovation Management
Life Science
$7M20 Jul 2021 Chiyoda, Japan

Career Essence

Employment
Human Resources
Recruiting
22 Jun 2021 Chiyoda, Japan

EditForce

Biotechnology
$7M26 May 2021 Fukuoka, Fukuoka Prefecture, Japan

ThinkCyte

Biotechnology
Life Science
Therapeutics
$26M19 May 2021 Bunkyo, Japan

anyCarry

Delivery Service
Logistics
Sharing Economy
09 Apr 2021 Chiyoda, Japan

CureApp

Health Care
Medical
$19M12 Mar 2021 Chiyoda, Japan

MFS

Finance
Financial Services
Real Estate
$5M15 Feb 2021 Chiyoda, Japan
News
OriCiro Genomics Raises ¥800M in Series B Financing

– OriCiro Genomics is a Tokyo, Japan-based pioneer in cell-free synthesis and amplification of genome-scale large DNA for advanced therapy and synthetic biology.
– Series B ¥800m round led by The University of Tokyo Edge Capital Partners (UTEC) with participation of ITOCHU Technology Ventures.
– Also received a ¥200m long-term loan from Japan Finance Corporation (JFC), a government-affiliated financial institution, totaling ¥1b in this round of financing.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent ITOCHU Technology Ventures?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: